Comparison of various calpain inhibitors in reduction of light scattering, protein precipitation and nuclear cataract in vitro

Reference

• Gupta SK. Prevalence and risk factors of cataract in In-dia, a review. Dev Ophthalmol. 1997;27:1–5.
   PubMedGoogle Scholar
• Waddell KM. Eliminating global avoidable blindness. J.R.Coll Physicians Lond. 1999;33 (6):568–573 .
   PubMedGoogle Scholar
• Wegener A. A 40 years crusade through the universe of lens research. Ophthalmic Res. 1995;27Supp1.1: 3–7.
   Google Scholar
• Hockwin 0. What possibilities exist to modify cataract development on the basis of current biochemical knowl-edge? Where can drugs act? Klin Monatsblat Augenheillcd. 1985;186(6):455–461.
   Google Scholar
• Hockwin 0, Kojima M, SadamotoY, Wegener A, Shui YB, Sasaki, K. UV damage to the eye lens: Further results from animal model studies: a review. J Epidemiol. 1999; (6suppl): S39–S47.
   Google Scholar
• Delcourt C, Cristol JP, Tessier F, Leger CL, Michel F, Papoz L. Risk factors for cortical, nuclear and posterior subcapsular cataracts; the POLA study (Pathologies Ocul-aires Lie es a 1 Age). Am J Epidemiol. 2000;151:497–504.
   PubMed Web of Science ®Google Scholar
• Shearer TR, David LL, Anderson RS, Azuma M. Review of selenite cataract. Curr Eye Res. 1992; 11(4):357–362.
   PubMed Web of Science ®Google Scholar
• Croall DE, deMartino GN. Calcium activated neutral pro-tease (calpain) system: Structure, function and regulation. Physiol Rev. 1991;71:813–847.
   PubMed Web of Science ®Google Scholar
• Iizuka K, Kawaguchi H, Yasuda H. Calpain is activated during hypoxic myocardial cell injury. Biochem Med Metab Biol. 1991;46:427–431.
   PubMedGoogle Scholar
• Lee KS, Frank S, Vanderklish P, Arai A, Lynch G. In-hibition of proteolysis protects hippocampal neurons from proteolysis. Proc Natl Acad Sci USA. 1991;88:7233–7237.
   PubMed Web of Science ®Google Scholar
• Wang KKW, Yuen PW. Calpain inhibition: An overview of its therapeutic potential. Trends Pharmacol Sci. 1994; 15:412–419.
   PubMed Web of Science ®Google Scholar
• Yuen P, Wang KKW. Calpain inhibitors: Novel neuropro-tectants and anticataract agents. Drugs of the Future. 1998; 3(7):741–749.
   Google Scholar
• Wang KKW, Yuen PW. Development and therapeutic potential of calpain inhibitors. Advances in Pharmacology. 1997;37:17–151.
   Google Scholar
• Wang KKW. Developing selective inhibitors of calpain. Trends Pharmacol Sci. 1990;11:139–142.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Murachi T, Tsukahara I. Distribution of calpain I, calpain II and calpastatin in bovine lens. Invest Ophthalmol Vis Sci. 1985;26:953–956.
   PubMed Web of Science ®Google Scholar
• Shearer TR, Ma H, Shih M, Hata I, Fukiage C, Nakamura Y, Azuma, M. Lp82 calpain during rat lens maturation and cataract formation. Curr Eye Res. 1998;17(11):1037–1043.
   PubMed Web of Science ®Google Scholar
• Ma H, Hata IL, Shih M, Fukiage C, Nakamura Y, Azuma M, Shearer TR. Lp82 is the dominant form of calpain in young mouse lens. Exp Eye Res. 1998;68(4):447–456.
   Google Scholar
• Azuma M, Fukiage C, David LL, Shearer TR. Activation of calpain in lens: A review and a proposed mechanism. Exp Eye Res. 1997;64:529–538.
   PubMed Web of Science ®Google Scholar
• Azuma M, Shearer TR, Matsumoto T, David LL, Mu-rachi,T. Calpain II in two in vivo models of sugar cataract. Exp Eye Res. 1990;51:393–401.
   PubMed Web of Science ®Google Scholar
• Chandrasekher G, Cenedella RJ. Calcium activated pro-teolysis and protein modification in the Ul 8666A cata-ract. Exp Eye Res. 1993;57:737–745.
   PubMed Web of Science ®Google Scholar
• David LL, Wright JW, Shearer TR. Calpain II insolubili-sation of lens f3 crystallin polypeptides may induce cata-ract. Biochem Biophys Acta. 1992;1139:210–216.
   Google Scholar
• David LL, Varnum MD, Lampi KJ, Shearer TR. Capain II in human lens. Invest Ophthalmol and Vis Sci. 1989;30: 269–275.
   PubMed Web of Science ®Google Scholar
• Kramps HA, Hoenders HA, Wollensak J. Protein changes in the human lens during development of senile nuclear cataract. Biochim Biophys Acta.1976;434:32–43 .
   PubMed Web of Science ®Google Scholar
• Duncan G, Hightower KR, Gandolfi SA, Tomlinson J, Maraini G. Human lens cation permeability increases with age. Invest Ophthalmol Vis Sci.1989;30:1855–1859.
   PubMed Web of Science ®Google Scholar
• Harding JJ. Human Cataract. In Harding JJ, ed. Cataract: Biochemistry, Epidemiology, and Pharmacology. New York: Chapman and Hall;1991:125–194.
   Google Scholar
• Tagliavini J, Gandolfi SA, Mariani G. Cytoskeleton ab-normalities in human senile cataract. Curr Eye Res. 1986; 5:903–10.
   PubMed Web of Science ®Google Scholar
• Shearer TR, Shih M, Azuma M, David LL. Precipitation of crystallins from young rat lens by endogenous calpain. Exp Eye Res. 1995;61:141–150.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for quanti-tation of microgram quantities of proteins utilising the principles of protein dye binding. Anal Biochem. 1976;72: 248–254.
   PubMed Web of Science ®Google Scholar
• Bours J, Hockwin 0. Biochemistry of the aging rat lens II. Isoelectric focusing of water soluble crystallins. Oph-thalmic Res. 1983;15(5):234–9.
   Google Scholar
• Bours J, Ahrend MHJ, Wegener A, Breipohl W. The glycation of bovine lens f3 and y crystallin demonstrated by frozen sectioning and isoelectric focussing. Vision Res. 1995;35:S198.
   Web of Science ®Google Scholar
• Rink H, Bours J, Hoenders HJ. Guidelines for the classifi-cation of lenses and the characterisation of lens proteins. Ophthalmic Res. 1982;14:284–291.
   Google Scholar
• Kadoya K, Azuma M, David LL, Shearer TR. Role of calpain in hydrogen peroxide induced cataract. Curr Eye Res. 1993 ; 12 (4):341–346.
   PubMed Web of Science ®Google Scholar
• Iwasaki N, David LL, Shearer TR. Crystallin degradation and insolubilisation in regions of young rat lens with cal-cium ionophore cataract. Invest Ophthalmol Vis Sci. 1995; 36:502–509.
   Google Scholar
• Sanderson J, Marcantonio JM, Duncan G. Calcium iono-phore induced proteolysis and cataract: Inhibition by cell permeable calpain antagonists. Biochim Biophys Res Comm. 1996;218:893–901.
   Google Scholar